Mechanisms of improved exercise tolerance in COPD in response to tiotropium

D. E. O'Donnell, H. Magnussen, F. Gerken, S. Kesten, T. Fluege (Kingston, Canada; Grosshansdorf, Ingelheim, Germany; Ridgefield, United States Of America)

Source: Annual Congress 2002 - Exercise and rehabilitation in patients with COPD
Session: Exercise and rehabilitation in patients with COPD
Session type: Thematic Poster Session
Number: 1826
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. E. O'Donnell, H. Magnussen, F. Gerken, S. Kesten, T. Fluege (Kingston, Canada; Grosshansdorf, Ingelheim, Germany; Ridgefield, United States Of America). Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur Respir J 2002; 20: Suppl. 38, 1826

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of formoterol on exercise tolerance in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 214s
Year: 2004

Budesonide/formoterol improves exercise tolerance compared with placebo and formoterol in COPD patients
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009


Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006

Effects of tiotropium on neurohumoral activation during exercise in stable COPD patients
Source: Annual Congress 2009 - Next generation bronchodilators
Year: 2009


Comparative effects of formoterol monotherapy versus formoterol plus tiotropium on dynamic hyperinflation and exercise tolerance in COPD
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009



The impact of tiotropium for exercise induced bronchoconstriction
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017


Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002

Efficacy of tiotropium and indacaterol alone or the combination on dynamic lung hyperinflation and exercise tolerance in COPD
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Impact of bronchodilator on pulmonary function and exercise tolerance in LAM
Source: Annual Congress 2011 - Lung and airway function
Year: 2011


Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

LABA-LAMA combination is superior to LABA monotherapy in improving the cardiocirculatory responses to treadmill exercise in patients with moderate-to-severe COPD
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010


Effects of inhaled formoterol on dynamic hyperinflation during and after incremental treadmill exercise in patients with advanced COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 172s
Year: 2006

Metronome-paced hyperventilation, CT measurements and exercise to investigate dynamic hyperinflation contrasting tiotropium versus indacaterol treatment in moderate COPD patients
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015


The inflammatory response to high doses of terbutaline during an acute exercise bout in patients with severe COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013

Physiological determinants of reduced tolerance to interval exercise in moderate-to-severe COPD
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016


Exercise tolerance with helium-hyperoxia versus hyperoxia in hypoxaemic patients with COPD
Source: Eur Respir J 2013; 42: 362-370
Year: 2013



Effect of a single dose of formoterol and tiotropium in exercise tolerance in COPD patients: preliminary data
Source: Eur Respir J 2003; 22: Suppl. 45, 405s
Year: 2003

Impact of exercise modality on exercise tolerance and functional capacity in patients with COPD
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol
Source: Eur Respir J 2001; 17: 368-373
Year: 2001